Amanta Healthcare IPO

About Amanta Healthcare IPO

Amanta Healthcare IPO is a book build issue worth ₹126.00 crore. The entire issue consists of a fresh issue of 1.00 crore equity shares amounting to ₹126.00 crore. The IPO will open for subscription on September 1, 2025, and close on September 3, 2025. 

The allotment of shares is expected to be finalised on September 4, 2025, and the shares are likely to be listed on BSE and NSE with a tentative listing date set for September 9, 2025. The price band for Amanta Healthcare IPO is fixed between ₹120.00 and ₹126.00 per share. 

The minimum lot size is 119 shares, requiring a retail investor to invest at least ₹14,994 at the upper price band. For non-institutional investors, the lot size investment differs: sNII is required to apply for 14 lots (1,666 shares) amounting to ₹2,09,916, while bNII needs to apply for 67 lots (7,973 shares) worth ₹10,04,598.

Beeline Capital Advisors Private Limited is acting as the book running lead manager for this issue, while MUFG Intime India Private Limited has been appointed as the registrar.

Amanta Healthcare IPO Objectives 

The company plans to allocate the net proceeds from the issuance to the following purposes:

1. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat.
2. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat. 
3. The company plans to allocate funds towards overall business growth, strengthening operations, and supporting future opportunities.

About Amanta Healthcare Limited 

Amanta Healthcare Limited is a pharmaceutical company focused on developing, manufacturing, and marketing a wide range of sterile liquid products. The company specialises in parenteral products packed in plastic containers using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technology. 

Its portfolio includes both Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), along with medical devices. The therapeutic segments covered include fluid therapy (IV fluids), formulations, diluents, ophthalmic, respiratory care, and irrigation solutions. 

In the medical devices category, the company produces irrigation solutions, first-aid solutions, and eye lubricants. The company provides multiple closure systems such as nipple head, twist-off, leur-lock, and screw types, with container sizes ranging from 2 ml to 1000 ml. 

Supported by dedicated formulation and development (F&D) and quality control laboratories in Hariyala, District Kheda, Gujarat, the company works on both new formulations and improvements to existing ones. Its manufacturing facilities hold GMP certifications from global regulatory authorities, including WHO-recommended standards, and are approved for exports by several countries.

Amanta Healthcare markets products under its own brands in India through a strong network of 316 distributors and stockists, while also exporting to 19 countries across Africa, Latin America, the UK, and other regions. With a portfolio of 47 products registered in 112 international jurisdictions, the company operates through three key business units: national sales, international sales, and product partnering. 

Its experienced management team and skilled workforce of professionals continue to support innovation, regulatory compliance, and growth in the pharmaceutical sector.

Industry Outlook

1. Global healthcare expenditure touched US$ 9.8 trillion in 2021, accounting for ~10% of global GDP. Rising chronic diseases, lifestyle changes, and increasing access to healthcare are expected to drive further growth in the pharmaceutical industry. 
2. India’s pharmaceutical formulation exports reached USD 12.3 billion to regulated markets in fiscal 2024, with the US contributing ~66% and Europe ~24%. Exports to semi-regulated markets stood at USD 10.1 billion, driven by Africa, Asia, Russia, and Latin America. Formulation exports are projected to grow 6–8% in fiscal 2025, supported by new launches and easing pricing pressures.
3. Exports to regulated markets are expected to grow by 11–13% in fiscal 2025, aided by new product launches in the US, demand from Europe, and rising opportunities in Canada and Japan.

How To Apply for the Amanta Healthcare IPO Online?

1. Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.
3. Select IPO: Find and select the Amanta Healthcare IPO from the list of open IPOs.
4. Enter the Lot Size: Specify the number of lots you want to bid for.
5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.

How To Check the Allotment Status of Amanta Healthcare IPO?

Steps to check IPO allotment status on Angel One’s app:

1. Log in to the Angel One app.
2. Go to the IPO Section and then to IPO Orders.
3. Select the individual IPO that you had applied for and check the allotment status.
4. Angel One will notify you of your IPO allotment status via push notification and email.

Contact Details of Amanta Healthcare Limited 

Registered office: 8th Floor, Shaligram Corporates, C.J. Marg, Ambli, Ahmedabad –380058, Gujarat, India

Phone: 079 67777600

E-mail:cs@amanta.co.in

Amanta Healthcare IPO Reservation

Amanta Healthcare IPO Lot Size Details

Amanta Healthcare IPO Promoter Holding

The promoters of the company include Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.

Note: Equity dilution will be determined by subtracting the Shareholding Post Issue from the Shareholding Pre Issue.

Key Performance Indicators for Amanta Healthcare IPO

Amanta Healthcare IPO Prospectus

• Amanta Healthcare IPO DRHP
• Amanta Healthcare IPO RHP

Amanta Healthcare IPO Registrar and Lead Managers

Amanta Healthcare IPO Lead Managers

• Beeline Capital Advisors Private Limited

Registrar for Amanta Healthcare IPO

MUFG Intime India Private Limited

• Contact Number: +91-22-4918 6270
• Email Address: amantahealthcare.ipo@linkintime.co.in
• Amanta Healthcare IPO Registrar: https://linkintime.co.in/Initial_Offer/public-issues.html